Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Should formula for infants provide arachidonic acid along with DHA?: A position paper of the European Academy of Paediatrics and the Child Health Foundation
Visa övriga samt affilieringar
2020 (Engelska)Ingår i: American Journal of Clinical Nutrition, ISSN 0002-9165, E-ISSN 1938-3207, Vol. 111, nr 1, s. 10-16Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Recently adopted regulatory standards on infant and follow-on formula for the European Union stipulate that from February 2020 onwards, all such products marketed in the European Union must contain 20-50 mg omega-3 DHA (22:6n-3) per 100 kcal, which is equivalent to about 0.5-1% of fatty acids (FAs) and thus higher than typically found in human milk and current infant formula products, without the need to also include co-6 arachidonic acid (AA; 20:4n-6). This novel concept of infant formula composition has given rise to concern and controversy because there is no accountable evidence on its suitability and safety in healthy infants. Therefore, international experts in the field of infant nutrition were invited to review the state of scientific research on DHA and AA, and to discuss the questions arising from the new European regulatory standards. Based on the available information, we recommend that infant and follow-on formula should provide both DHA and AA. The DHA should equal at least the mean content in human milk globally (0.3% of FAs) but preferably reach 0.5% of FAs. Although optimal AA intake amounts remain to be defined, we strongly recommend that AA should be provided along with DHA. At amounts of DHA in infant formula up to similar to 0.64%, AA contents should at least equal the DHA contents. Further well-designed clinical studies should evaluate the optimal intakes of DHA and AA in infants at different ages based on relevant outcomes.

Ort, förlag, år, upplaga, sidor
OXFORD UNIV PRESS , 2020. Vol. 111, nr 1, s. 10-16
Nyckelord [en]
infant nutrition, breast milk substitutes, long-chain PUFAs, European Commission Formula Delegated Act 2016/127, food safety
Nationell ämneskategori
Näringslära Pediatrik
Identifikatorer
URN: urn:nbn:se:umu:diva-167971DOI: 10.1093/ajcn/nqz252ISI: 000505964300005PubMedID: 31665201Scopus ID: 2-s2.0-85077624608OAI: oai:DiVA.org:umu-167971DiVA, id: diva2:1394962
Tillgänglig från: 2020-02-20 Skapad: 2020-02-20 Senast uppdaterad: 2023-03-23Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Domellöf, MagnusHernell, Olle

Sök vidare i DiVA

Av författaren/redaktören
Colombo, JohnDomellöf, MagnusHernell, Olle
Av organisationen
Pediatrik
I samma tidskrift
American Journal of Clinical Nutrition
NäringsläraPediatrik

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 227 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf